US Stock MarketDetailed Quotes
POAI Predictive Oncology
- 1.4300
- -0.3300-18.75%
Close May 31 16:00 ET
- 1.4300
- 0.00000.00%
Post 19:59 ET
5.87MMarket Cap-390P/E (TTM)
1.7811High1.2900Low431.15KVolume1.7100Open1.7600Pre Close685.85KTurnover11.86%Turnover RatioLossP/E (Static)4.10MShares7.120052wk High1.45P/B5.20MFloat Cap1.120052wk Low--Dividend TTM3.64MShs Float1910.0000Historical High--Div YieldTTM27.90%Amplitude1.1200Historical Low1.5900Avg Price1Lot Size
Predictive Oncology Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 74.93%419.65K | 18.24%1.78M | -7.82%335.03K | 56.87%715.06K | 31.90%490.11K | -23.74%239.9K | 5.97%1.51M | -23.72%363.47K | 45.32%455.83K | 6.11%371.59K |
| Operating revenue | 74.93%419.65K | 18.24%1.78M | -7.82%335.03K | 56.87%715.06K | 31.90%490.11K | -23.74%239.9K | 5.97%1.51M | -23.72%363.47K | 45.32%455.83K | 6.11%371.59K |
| Cost of revenue | 56.00%187.42K | 25.68%634.8K | 61.60%247.96K | -1.12%106.94K | 19.16%159.76K | 9.77%120.14K | 3.71%505.11K | 12.64%153.44K | -1.83%108.15K | -6.16%134.08K |
| Gross profit | 93.92%232.23K | 14.49%1.15M | -58.54%87.08K | 74.91%608.12K | 39.08%330.35K | -41.62%119.76K | 7.14%1M | -38.27%210.04K | 70.85%347.68K | 14.56%237.52K |
| Operating expense | 24.67%4.47M | -7.39%15.07M | -22.54%3.59M | -15.99%3.76M | 16.84%4.13M | -0.95%3.58M | 12.93%16.27M | -2.47%4.64M | 55.32%4.48M | 25.89%3.53M |
| Selling and administrative expenses | 29.74%3.21M | -12.27%10.94M | -37.67%2.18M | -19.38%2.92M | 19.48%3.13M | -9.28%2.48M | 6.52%12.47M | -9.14%3.5M | 62.08%3.62M | 17.20%2.62M |
| -Selling and marketing expense | 99.80%739.73K | 11.18%1.51M | -16.57%375.48K | 0.80%336.04K | 58.33%429.1K | 21.60%370.24K | 75.45%1.36M | 37.53%450.04K | 92.85%333.38K | 69.61%271.02K |
| -General and administrative expense | 17.42%2.47M | -15.14%9.43M | -40.79%1.8M | -21.42%2.58M | 15.00%2.7M | -13.16%2.1M | 1.63%11.11M | -13.47%3.05M | 59.49%3.29M | 13.17%2.35M |
| Depreciation amortization depletion | -32.65%155.7K | ---- | ---- | ---- | ---- | --231.19K | ---- | ---- | ---- | ---- |
| -Depreciation and amortization | -32.65%155.7K | ---- | ---- | ---- | ---- | --231.19K | ---- | ---- | ---- | ---- |
| Other operating expenses | 25.46%1.1M | 8.66%4.13M | 23.84%1.41M | -1.70%842.58K | 9.23%993.04K | -1.41%878.52K | 40.76%3.8M | 25.81%1.14M | 32.08%857.13K | 60.11%909.11K |
| Operating profit | -22.27%-4.24M | 8.82%-13.92M | 20.83%-3.51M | 23.64%-3.15M | -15.24%-3.8M | -1.49%-3.46M | -13.33%-15.27M | -0.29%-4.43M | -54.15%-4.13M | -26.79%-3.29M |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | -58.48%17.93K | 99.40%-62.64K | 100.88%30.6K | -113.15%-9.37K | 98.21%-127.05K | -0.39%43.18K | -52.91%-10.47M | 12.86%-3.49M | 102.58%71.27K | -29,311.81%-7.1M |
| Gain on sale of security | 5.88%1.01K | -89.23%12.46K | -91.13%733 | -66.11%3.46K | -92.33%7.31K | -50.05%953 | -29.87%115.65K | -91.39%8.27K | 147.91%10.22K | 408.18%95.25K |
| Special income (charges) | ---- | 98.49%-162.91K | --0 | --0 | 97.75%-162.91K | ---- | -54.75%-10.77M | 14.68%-3.53M | --0 | ---7.23M |
| -Less:Impairment of capital assets | ---- | -98.49%162.91K | --0 | --0 | -97.75%162.91K | ---- | 54.75%10.77M | -14.68%3.53M | --0 | --7.23M |
| Other non- operating income (expenses) | -59.93%16.92K | -51.32%87.81K | -23.54%29.86K | -121.02%-12.83K | -26.47%28.55K | 1.90%42.23K | 427.33%180.37K | -13.19%39.05K | 18.73%61.05K | -29.66%38.83K |
| Income before tax | -23.29%-4.22M | 45.67%-13.98M | 56.10%-3.48M | 22.07%-3.16M | 62.24%-3.92M | -1.52%-3.42M | -26.67%-25.74M | 5.96%-7.92M | 25.35%-4.06M | -303.71%-10.39M |
| Income tax | ||||||||||
| Net income | -23.29%-4.22M | 45.67%-13.98M | 56.10%-3.48M | 22.07%-3.16M | 62.24%-3.92M | -1.52%-3.42M | -30.93%-25.74M | -2.06%-7.92M | 25.35%-4.06M | -303.71%-10.39M |
| Net income continuous Operations | -23.29%-4.22M | 45.67%-13.98M | 56.10%-3.48M | 22.07%-3.16M | 62.24%-3.92M | -1.52%-3.42M | -30.93%-25.74M | -2.06%-7.92M | 25.35%-4.06M | -303.71%-10.39M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -23.29%-4.22M | 45.67%-13.98M | 56.10%-3.48M | 22.07%-3.16M | 62.24%-3.92M | -1.52%-3.42M | -30.93%-25.74M | -2.06%-7.92M | 25.35%-4.06M | -303.71%-10.39M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -23.29%-4.22M | 45.67%-13.98M | 56.10%-3.48M | 22.07%-3.16M | 62.24%-3.92M | -1.52%-3.42M | -30.93%-25.74M | -2.06%-7.92M | 25.35%-4.06M | -303.71%-10.39M |
| Basic earnings per share | -20.93%-1.04 | 50.14%-3.48 | 58.13%-0.85 | 25.00%-0.78 | 66.09%-0.98 | 15.69%-0.86 | 3.06%-6.98 | 21.92%-2.03 | 35.00%-1.04 | -189.00%-2.89 |
| Diluted earnings per share | -20.93%-1.04 | 50.14%-3.48 | 58.13%-0.85 | 25.00%-0.78 | 66.09%-0.98 | 15.69%-0.86 | 3.06%-6.98 | 21.92%-2.03 | 35.00%-1.04 | -189.00%-2.89 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg